These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32816634)

  • 21. The burden of drug resistant tuberculosis in a predominantly nomadic population in Uganda: a mixed methods study.
    Simbwa BN; Katamba A; Katana EB; Laker EAO; Nabatanzi S; Sendaula E; Opio D; Ictho J; Lochoro P; Karamagi CA; Kalyango JN; Worodria W
    BMC Infect Dis; 2021 Sep; 21(1):950. PubMed ID: 34521382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'I didn't know so many people cared about me': support for patients who interrupt drug-resistant TB treatment.
    Snyman L; Venables E; Trivino Duran L; Mohr E; Azevedo VD; Harmans X; Isaakidis P
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):1023-1030. PubMed ID: 30092867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "I would watch her with awe as she swallowed the first handful": A qualitative study of pediatric multidrug-resistant tuberculosis experiences in Durban, South Africa.
    Misra S; Misra N; Seepamore B; Holloway K; Singh N; Ngozo J; Dlamini V; Radebe Z; Ndjeka NO; Furin J
    PLoS One; 2022; 17(9):e0274741. PubMed ID: 36112604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria.
    Bajehson M; Musa BM; Gidado M; Nsa B; Sani U; Habibu AT; Aliyu I; Hussaini T; Yusuf A; Gida Y
    PLoS One; 2019; 14(11):e0225165. PubMed ID: 31743358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.
    Bieh KL; Weigel R; Smith H
    BMC Infect Dis; 2017 Jan; 17(1):50. PubMed ID: 28068907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
    Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.
    Dzeyie KA; Basu S; Dikid T; Bhatnagar AK; Chauhan LS; Narain JP
    Indian J Tuberc; 2019 Jul; 66(3):331-336. PubMed ID: 31439176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.
    Moyo S; Cox HS; Hughes J; Daniels J; Synman L; De Azevedo V; Shroufi A; Cox V; van Cutsem G
    PLoS One; 2015; 10(3):e0118919. PubMed ID: 25785451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Directly observed therapy for treating tuberculosis.
    Karumbi J; Garner P
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003343. PubMed ID: 26022367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
    Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
    PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The social implications of participant choice on adherence to Isonaizid Preventive Therapy (IPT): A follow-up study to high completion rates in Eswatini.
    Grande SW; Adams LV; Maseko TSB; Talbot EA; deGijsel D; Mikal J; Simelane ZZ; Achili A; Mkhontfo M; Haumba SM
    PLoS One; 2020; 15(5):e0232841. PubMed ID: 32469990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.
    Pradipta IS; Van't Boveneind-Vrubleuskaya N; Akkerman OW; Alffenaar JC; Hak E
    Antimicrob Resist Infect Control; 2019; 8():115. PubMed ID: 31338162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal.
    Khanal S; Elsey H; King R; Baral SC; Bhatta BR; Newell JN
    PLoS One; 2017; 12(1):e0167559. PubMed ID: 28099475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming challenges in the diagnosis, prevention, and treatment of pediatric drug-resistant tuberculosis.
    Jonckheree S; Furin J
    Expert Rev Respir Med; 2017 May; 11(5):385-394. PubMed ID: 28319425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study.
    Das M; Mathur T; Ravi S; Meneguim AC; Iyer A; Mansoor H; Kalon S; Hossain FN; Acharya S; Ferlazzo G; Isaakidis P; Thakur HP
    PLoS One; 2021; 16(3):e0248408. PubMed ID: 33690715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting.
    Metcalfe J; Bacchetti P; Esmail A; Reckers A; Aguilar D; Wen A; Huo S; Muyindike WR; Hahn JA; Dheda K; Gandhi M; Gerona R
    BMC Infect Dis; 2021 Jan; 21(1):99. PubMed ID: 33482745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa.
    Sineke T; Evans D; Schnippel K; van Aswegen H; Berhanu R; Musakwa N; Lönnmark E; Long L; Rosen S
    Health Qual Life Outcomes; 2019 May; 17(1):94. PubMed ID: 31151398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance.
    Hameed S; Ahmad SR; Rahman MAU; Nazir H; Ullah I
    J Glob Antimicrob Resist; 2019 Sep; 18():155-159. PubMed ID: 30910744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis.
    Isaakidis P; Rangan S; Pradhan A; Ladomirska J; Reid T; Kielmann K
    Trop Med Int Health; 2013 Sep; 18(9):1128-1133. PubMed ID: 23837468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "The right time is just after birth": acceptability of point-of-care birth testing in Eswatini: qualitative results from infant caregivers, health care workers, and policymakers.
    Sacks E; Khumalo P; Tsabedze B; Montgomery W; Mthethwa N; Nhlabatsi B; Masuku T; Cohn J; Chouraya C
    BMC Pediatr; 2020 Jul; 20(1):347. PubMed ID: 32669131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.